Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

Clinical trial NCT01109069 · COMPLETED

Trial details

NCT number: NCT01109069
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-cell Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Diffuse Well-differentiated Lymphocytic Lymphoma B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Non-Hodgkin's Lymphoma Waldenstrom Macroglobulinemia Burkitt Lymphoma B-Cell Diffuse Lymphoma

Start date: 2010-06-01
Primary completion: 2019-04-26
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.